Status:

NOT_YET_RECRUITING

INDUCE: A Prospective 2-Year Spine Registry

Lead Sponsor:

Red Rock Regeneration Inc.

Conditions:

Subjects Treated With NMP as Part of Their Spine Surgery

Degenerative Disc Disease (DDD)

Eligibility:

All Genders

18+ years

Brief Summary

The primary objective of this prospective, observational registry study is to evaluate the safety and effectiveness of Natural Matrix Protein® (NMP®) when used to promote fusion in the cervical or lum...

Detailed Description

This is a multicenter, observational, prospective registry study of up to 1,000 patients across a maximum of 10 US sites. All subjects who meet study entrance criteria and planned to be treated with N...

Eligibility Criteria

Inclusion

  • Implanted on-label with NMP in at least one vertebral level in the cervical (C1-C7) or lumbar (L1-S1) spine as part of their surgery
  • Total volume of bone graft or bone graft substitute used in index surgery must contain at least 50% NMP by volume per treated level, where NMP is mixed with other graft material.
  • Skeletally mature (age≥18 years of age)
  • Be willing to sign the study-specific informed consent document prior to index surgery

Exclusion

  • Not willing to sign the study-specific informed consent document prior to index surgery
  • Use of allogenic growth factor extacts (i.e. OsteoFactor/ProteiOS) or cell based allografts as part of the index surgery (use of autograft or bone marrow aspirate (BMA) is allowed)
  • Use of rhBMP-2 (i.e. INFUSE) or synthetic peptide enhanced graft (i.e. iFactor) as part of the index surgery
  • Diagnosis of spinal deformity (greater than 20 degrees) or vertebral fracture including treated level
  • Unable to comply with postoperative standard of care imaging (e.g. pregnant or nursing female)
  • Did not complete baseline patient reported outcomes prior to index surgery
  • Incarcerated at the time of surgery or preoperative evaluation

Key Trial Info

Start Date :

October 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2029

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT06971835

Start Date

October 1 2025

End Date

January 1 2029

Last Update

July 22 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

INDUCE: A Prospective 2-Year Spine Registry | DecenTrialz